Expression of miR-133 and miR-30 in chronic atrial fibrillation in canines

Molecular Medicine Reports

Volumn 5, Issue 6, 2012, Pages 1457-1460

  Li, Hongli ^a   Li, Shufeng ^b   Yu, Bo ^b   Liu, Shaowen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Atrium; Fibrosis; miR 133; miR 30

Indexed keywords

MICRORNA; MICRORNA 133; MICRORNA 30; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOG; DOWN REGULATION; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HISTOLOGY; MALE; NONHUMAN; NORTHERN BLOTTING; PHYSICAL EXAMINATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ATRIAL FIBRILLATION; CHRONIC DISEASE; DOGS; DOWN-REGULATION; FEMALE; MALE; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84860716719     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.831     Document Type: Article

References (14)

1. Stewart S, Hart CL, Hole DJ and McMurray JJ: Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart 86: 516-521, 2001. (Pubitemid 32999861)
2. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, et al: Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 12: 1360-1420, 2010.
3. Kistler PM, Sanders P, Dodic M, Spence SJ, Samuel CS, Zhao C, Charles JA, Edwards GA and Kalman JM: Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J 27: 3045-3056, 2006. (Pubitemid 44950450)
4. Cardin S, Libby E, Pelletier P, Le Bouter S, Shiroshita-Takeshita A, Le Meur N, Léger J, Demolombe S, Ponton A, Glass L and Nattel S: Contrasting gene expression profiles in two canine models of atrial fibrillation. Circ Res 100: 425-433, 2007.
5. Wachtell K, Gerdts E, Aurigemma GP, Boman K, Dahlöf B, Nieminen MS, Olsen MH, Okin PM, Palmieri V, Rokkedal JE and Devereux RB: In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: the LIFE study. Blood Press 19: 169-175, 2010.
6. Han M, Toli J and Abdellatif M: MicroRNAs in the cardiovascular system. Curr Opin Cardiol 26: 181-189, 2011.
7. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J and Olson EN: Control of stress dependent cardiac growth and gene expression by a microRNA. Science 316: 575-579, 2007. (Pubitemid 46683138)
8. Luo X, Zhang H, Xiao J and Wang Z: Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications. Cell Physiol Biochem 25: 571-586, 2010.
9. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, Barenbrug P, et al: miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 104: 170-178, 2009.
10. Kumagai K, Khrestian C and Waldo AL: Simultaneous multisite mapping studies during induced atrial fibrillation in the sterile pericarditis model. Insights into the mechanism of its maintenance. Circulation 95: 511-521, 1997. (Pubitemid 27056221)
11. Wu TJ, Ong JJ, Chang CM, Doshi RN, Yashima M, Huang HL, Fishbein MC, Ting CT, Karagueuzian HS and Chen PS: Pulmonary veins and ligament of Marshall as sources of rapid activations in a canine model of sustained atrial fibrillation. Circulation 103: 1157-1163, 2001. (Pubitemid 32200192)
12. Li D, Fareh S, Leung TK and Nattel S: Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100: 87-95, 1999. (Pubitemid 29297945)
13. Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R and Olson EN: microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 22: 3242-3254, 2008.
14. Matkovich SJ, Wang W, Tu Y, Eschenbacher WH, Dorn LE, Condorelli G, Diwan A, Nerbonne JM and Dorn GW II: MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res 106: 166-175, 2010.